AKT1 and persistent truncus arteriosus: However, evidence on the association between the cardioprotective effects of QSYQ on TAC-induced heart failure and cardiac angiogenesis, as well as evidence on the association between the proangiogenic effects of QSYQ on TAC-induced heart failure and cardiac VEGF/Akt/eNOS pathway, is extremely weak.